49.JPG)
The Clinical Trial Planning and Design Services Market Size is predicted to reach at an 8.90 % CAGR during the forecast period for 2024-2031.
Key Industry Insights & Findings from the Report:
- Due to advances in research and medical technology, clinical trials are becoming increasingly complex. This complexity requires specialized expertise in test planning and design to ensure efficiency and compliance with regulatory standards.
- The globalization of clinical research has increased as pharmaceutical and biotech companies seek access to diverse patient populations and healthcare systems. Clinical trial planning services are essential to avoid the challenges of conducting trials in multiple geographies.
- North America dominated the market and accounted for a revenue share of global revenue in 2023.
- The increasing reliance on technology and electronic data collection in clinical research raises concerns about data security and patient privacy. Strict data protection regulations can complicate the planning and design of clinical trials.
The clinical trial is a protocol that studies new treatments and tests and checks their effects on human health. The clinical trial planning and design services offer data accuracy, adaptability, consistency, and compliance to clinical studies. Pharmaceutical companies use clinical trial planning and design services during the drug development process or molecular analysis of generics and biosimilars.
The factors such as increasing use of clinical trial management services, adoption of advanced medical technologies, and rising government investments for research and development of clinical trial protocols are expected to boost the market growth over the forecast period. Furthermore, increased R&D expenditure by the pharma and biotech companies and the rising prevalence of chronic and infectious diseases are fueling the growth of the clinical trial planning and design services market.
Leading players are emphasizing on global expansion in order to gain a huge market share. For instance, in Sept 2022, Cytel Inc.'s business expanded across the Asia-Pacific area (APAC). This makes Cytel's existing biometrics and advanced statistical solutions more accessible to APAC biotech and biopharma enterprises. Cytel now has offices in Australia, Shanghai, Beijing, and Singapore, with ambitions to grow into Seoul and Tokyo in the future. This expansion is the latest move in Cytel's mission to provide advanced analytics capabilities to drug developers worldwide.However, the high cost of devices with advanced technologies and poor reimbursement policies may downscale the market growth.
Competitive Landscape:
- Atlantia Clinical Trials
- PharmaLex
- Emergo UL
- Cytel
- Health Policy Associate
- CD BioSciences
- LLX Solutions
- SGS
- ADM Korea
- McDougall Scientific
- ClinAsia
- BioPoint
- IQVIA
- PPD, Inc.
- Veristat, LLC
- Clinical Accelerator
- Allied Clinical Management GmbH
- Parexel International Corporation
- Pepgra
- WIRB-Copernicus Group
- Other Prominent Players
Market Segmentation
The clinical trial planning and design services market is segmented based on trial phases, therapeutic areas, services, and regions. The Trial Phases segment is divided into Phase I, Phase II, Phase III, and Phase IV. Based on the therapeutic area, the market is divided into oncological disorders, cardiovascular disorders, inflammatory disorders, neurological disorders, and other therapeutic areas. The oncological disorders segment is the fastest-growing segment of the clinical trial planning and design market due to the rising prevalence of cancer. Furthermore, the neurological disorders segment is anticipated to boost the market, owing to the rise in neurology clinical trials. By Services, the market is segmented into statistical analysis plan, eCRF, site identification and selection, medical writing, and other services.
Based on the region, the clinical trial planning and design services market is divided into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. In 2021, North America dominated the clinical trial planning and design services market. The large share of the North American regional segment can be attributed to the increasing number of pharmaceutical companies, rising adoption of advanced medical technologies, and high clinical R&D investments by the government.
Some of the key players operating in the clinical trial planning and design services market are Atlantia Clinical Trials, PharmaLex, Emergo UL, Cytel, Health Policy Associate, CD BioSciences, LLX Solutions, SGS, ADM Korea, McDougall Scientific, ClinAsia, BioPoint, IQVIA, PPD, Inc., Veristat, LLC, Clinical Accelerator, Allied Clinical Management GmbH, Parexel International Corporation, Pepgra, WIRB-Copernicus Group, and other.
Recent Developments:
- In May 2023, CD Biosciences, an early phase clinical services provider for researchers worldwide announced that it will offer one-stop clinical trial services. The business says it can help scientists all around the world navigate the difficulties of developing clinical trials, with a focus on assisting them in reducing costs, minimizing risks, and expediting early-phase clinical trial times.
Clinical Trial Planning and Design Services Market Report Scope
|
Report Attribute |
Specifications |
|
Growth Rate CAGR |
CAGR of 8.90 % from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
Trial Phase, Therapeutic Area, Service |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Creative Biolabs, Medicago Inc., iBio, ICON, EEA Consulting Engineers, Kentucky BioProcessing, Inc., Baiya Phytopharm and Protalix Biotherapeutics. |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
